Life sciences giant Abcam has signed the lease for its new global headquarters at the Cambridge biomedical campus.

Abcam says the new site will combine its three current facilities in Cambridge into one new state-of-the-art global headquarters and will house the group’s UK innovation and manufacturing capabilities, laboratories, logistics, sales, marketing and corporate functions. It will also be the company’s European distribution hub.

The News reported that Abcam was planning to take space at the biomedical campus earlier this year, and the 100,000 sq ft scheme, will almost double the company’s footprint in Cambridge, which currently stands at 57,000 sq ft.

Alan Hirzel, Abcam’s CEO, said: “The Cambridge Biomedical Campus is rapidly becoming an influential hub for global life science. We are looking forward to building upon our longstanding relationships with the scientific community and establishing new relationships with other organisations on the site.

“Bringing the Abcam team together will improve our efficiency and innovation process to the benefit of all of our stakeholders.”

A resolution to grant planning approval was passed unanimously in early August with the construction project planned to begin once full approval is received.